Biomarker Testing as a Determinant of Treatment in Non-Small Cell Lung Cancer

22 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
(https://support.doctorpodcasting.com/media/k2/items/cache/895cf7748902c458bacb7522eb07062c_Generic.jpg)

Dr. Melina Marmarelis offers an overview of biomarker testing—and particularly liquid biopsy—as a fulcrum of precision medicine at Penn Medicine in the determination of tailored treatments for patients with metastatic non-small cell lung cancer.
Categoria
Oncology
Commenta per primo questo video.

Prossimo